MM
MUSSALLEM MICHAEL A Chief Executive Officer
CEO M
US US · SEC (Form 4)
Browse the complete record of transactions filed by MUSSALLEM MICHAEL A, Chief Executive Officer. Director active across 1 companies, notably Edwards Lifesciences Corp. In total, 30 disclosures have been published. The latest transaction was disclosed on 14 June 2022 — Levée d'options. Regulator: SEC (Form 4). The full history is openly available.
Declarations 30 total
€990,272 29,375 shares @ €33.7114 0.0020% mcap 5.4% of flow
Common Stock
SEC:0001225208-22-008106:0 · 14 Jun 2022
056,831 shares 0
Common Stock
SEC:0001225208-22-006818:0 · 8 May 2022
021,250 shares 0
Common Stock
SEC:0001225208-22-006577:0 · 3 May 2022
€933,234 45,050 shares @ €20.7155 0.0019% mcap 5.1% of flow
Common Stock
SEC:0001225208-22-006312:0 · 29 Apr 2022
€889,778 45,050 shares @ €19.7509 0.0018% mcap 4.9% of flow
Common Stock
SEC:0001225208-22-004988:0 · 22 Mar 2022
€867,025 45,050 shares @ €19.2458 0.0018% mcap 4.7% of flow
Common Stock
SEC:0001225208-22-002224:0 · 15 Feb 2022
€866,477 45,050 shares @ €19.2337 0.0018% mcap 11.9% of flow
Common Stock
SEC:0001225208-22-000614 · 6 Jan 2022
€866,477 45,050 shares @ €19.2337 0.0018% mcap 4.7% of flow
Common Stock
SEC:0001225208-22-000614:0 · 6 Jan 2022
€871,868 45,050 shares @ €19.3533 0.0018% mcap 11.9% of flow
Common Stock
SEC:0001225208-21-015166 · 20 Dec 2021
€871,868 45,050 shares @ €19.3533 0.0018% mcap 4.8% of flow
Common Stock
SEC:0001225208-21-015166:0 · 20 Dec 2021
€845,694 45,050 shares @ €18.7724 0.0017% mcap 11.6% of flow
Common Stock
SEC:0001225208-21-013738 · 9 Nov 2021
€845,694 45,050 shares @ €18.7724 0.0017% mcap 4.6% of flow
Common Stock
SEC:0001225208-21-013738:0 · 9 Nov 2021
€846,939 45,050 shares @ €18.80 0.0017% mcap 11.6% of flow
Common Stock
SEC:0001225208-21-012665 · 1 Oct 2021
€846,939 45,050 shares @ €18.80 0.0017% mcap 4.6% of flow
Common Stock
SEC:0001225208-21-012665:0 · 1 Oct 2021
€829,347 45,050 shares @ €18.4095 0.0017% mcap 11.4% of flow
Common Stock
SEC:0001225208-21-012422 · 15 Sept 2021
€829,347 45,050 shares @ €18.4095 0.0017% mcap 4.5% of flow
Common Stock
SEC:0001225208-21-012422:0 · 15 Sept 2021
€825,893 45,050 shares @ €18.3328 0.0017% mcap 11.3% of flow
Common Stock
SEC:0001225208-21-011090 · 3 Aug 2021
€825,893 45,050 shares @ €18.3328 0.0017% mcap 4.5% of flow
Common Stock
SEC:0001225208-21-011090:0 · 3 Aug 2021
€827,510 45,050 shares @ €18.3687 0.0017% mcap 11.3% of flow
Common Stock
SEC:0001225208-21-009995 · 1 Jul 2021
€827,510 45,050 shares @ €18.3687 0.0017% mcap 4.5% of flow
Common Stock
SEC:0001225208-21-009995:0 · 1 Jul 2021
€804,702 45,050 shares @ €17.8624 0.0016% mcap 4.4% of flow
Common Stock
SEC:0001225208-21-009152:0 · 9 Jun 2021
€804,702 45,050 shares @ €17.8624 0.0016% mcap 11.0% of flow
Common Stock
SEC:0001225208-21-009152 · 9 Jun 2021
€587,885 33,000 shares @ €17.8147 0.0012% mcap 8.0% of flow
Common Stock
SEC:0001225208-21-008559 · 24 May 2021
€587,885 33,000 shares @ €17.8147 0.0012% mcap 3.2% of flow
Common Stock
SEC:0001225208-21-008559:0 · 24 May 2021
069,562 shares 0
Common Stock
SEC:0001225208-21-008299 · 17 May 2021
25 of 30 declarations
Load more (5 remaining) About MUSSALLEM MICHAEL A MUSSALLEM MICHAEL A is the Chief Executive Officer of Edwards Lifesciences Corp.